Orion Biotech Opportunities Corp. Warrant
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- Book Value:
- Revenue TTM:
- Operating Margin TTM:
- Gross Profit TTM:
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Orion Biotech Opportunities Corp. Warrant had its IPO on 2021-07-07 under the ticker symbol ORIAW.
The company operates in the Financial Services sector and Shell Companies industry. Orion Biotech Opportunities Corp. Warrant has a staff strength of 0 employees.
Shares of Orion Biotech Opportunities Corp. Warrant opened at $0 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0 - $0, and closed at $0.
This is a -88% slip from the previous day's closing price.
A total volume of 10,000 shares were traded at the close of the day’s session.
In the last one week, shares of Orion Biotech Opportunities Corp. Warrant have slipped by -81.54%.
Orion Biotech Opportunities Corp. Warrant's Key Ratios
Orion Biotech Opportunities Corp. Warrant has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Orion Biotech Opportunities Corp. Warrant’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures Orion Biotech Opportunities Corp. Warrant's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Orion Biotech Opportunities Corp. Warrant’s operating margin was 0% while its return on assets stood at -0.28% with a return of equity of 0%.
In Q4, Orion Biotech Opportunities Corp. Warrant’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Orion Biotech Opportunities Corp. Warrant’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Orion Biotech Opportunities Corp. Warrant’s profitability.
Orion Biotech Opportunities Corp. Warrant stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Orion Biotech Opportunities Corp. Warrant stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $203.33 million
- Total Liabilities
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Orion Biotech Opportunities Corp. Warrant ended 2023 with $203.33 million in total assets and $0 in total liabilities. Its intangible assets were valued at $203.33 million while shareholder equity stood at $195.00 million.
Orion Biotech Opportunities Corp. Warrant ended 2023 with $0 in deferred long-term liabilities, $67593.00 in other current liabilities, 202793965.00 in common stock, $-7792939.00 in retained earnings and $0 in goodwill. Its cash balance stood at $265717.00 and cash and short-term investments were $265717.00. The company’s total short-term debt was $0 while long-term debt stood at $0.
Orion Biotech Opportunities Corp. Warrant’s total current assets stands at $439320.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $7718.00 and inventory worth $0.
In 2023, Orion Biotech Opportunities Corp. Warrant's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Orion Biotech Opportunities Corp. Warrant paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Orion Biotech Opportunities Corp. Warrant stock is currently trading at $0 per share. It touched a 52-week high of $0.6004 and a 52-week low of $0.6004. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.11 and 200-day moving average was $0.2 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Orion Biotech Opportunities Corp. Warrant
Similar Industry Stocks (Shell Companies)
Orion Biotech Opportunities Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company intends to acquire businesses in the biotechnology and life sciences sectors. Orion Biotech Opportunities Corp. was incorporated in 2021 and is based in New York, New York.